Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (BST:2TZ)
2.140
-0.080 (-3.60%)
At close: Nov 20, 2026
| Market Cap | 3.35B -10.6% |
| Revenue (ttm) | 612.46M -13.1% |
| Net Income | 117.58M -75.0% |
| EPS | 0.16 -75.0% |
| Shares Out | n/a |
| PE Ratio | 13.48 |
| Forward PE | n/a |
| Dividend | 0.60 (27.90%) |
| Ex-Dividend Date | Jun 29, 2026 |
| Volume | n/a |
| Open | 2.160 |
| Previous Close | 2.220 |
| Day's Range | 2.140 - 2.160 |
| 52-Week Range | 2.080 - 3.169 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 31, 2026 |